Skip to Content
  • Previous Rank
    -
  • Revenue 3 Yr Annual Growth Rate
    27%
  • Revenue 3 Yr Growth Rank
    52
  • EPS 3 Yr Annual Growth Rate
    34%
  • EPS 3 Yr Growth Rank
    57
  • Total Return 3 Yr Annual Rate
    25%
  • Total Return 3 Yr Rank
    48

The world’s only anthrax vaccine, BioThrax, brought in some 55% of revenues for this manufacturer of drugs to protect against bioterrorism and other threats.

Company Information

Revenue and net income for the four quarters ended on or before April 30, 2016.!Total return for the period ended June 30, 2016.
Location
Gaithersburg, Md.
Industry
Pharmaceuticals
Sector
Health Care
Current Streak-
Years on List1
CEO
Daniel Abdun-Nabi
Websitehttp://www.emergentbiosolutions.com
Created with sketchtool.
Looking for leads, investment insights, or competitive intelligence?
Purchase Now

Revenue, Net Income

Revenue Past Four Quarters ($M)$570
Net Income Past Four Quarters ($M)$88

Growth Rates and Ranks

Revenue 3 Yr Growth Rank52
EPS 3 Yr Annual Growth Rate34%
EPS 3 Yr Growth Rank57
Total Return 3 Yr Annual Rate25%
Total Return 3 Yr Rank
48